The day may soon come when surgery, chemo and radiation appear barbaric as brain cancer therapies- vaccines may become the new, effective standard-of-care
If you have been diagnosed with brain cancer I have good news and I have bad news. First, the bad news. Conventional (FDA approved) oncology has little to offer you other than expensive chemo and radiation with a good chance of nasty collateral damage.
Now the good news. As the studies linked and excerpted below explain, vaccines may become the new, effective standard-of-care for brain cancer. The hitch is that this technology is constantly changing. A post I write today, July 24th, 2017, may be out-of-date by the time you read it.
I am both a cancer survivor and cancer coach. I work with cancer patients to research both conventional and non-conventional (vaccines…) therapies for their type and stage of cancer.
Have you been diagnosed with brain cancer? What type? What stage? Please scroll down the page, post a question or comment and I will reply to you ASAP.
Thanks and hang in there,
- Cancer Survivor
- Cancer Coach
- Director PeopleBeatingCancer
“Here we present current retrospective data on 50 patients with glioblastoma who received valganciclovir as an add-on to standard therapy at Karolinska University Hospital as adjuvant treatment (Section S2 in the Supplementary Appendix). The rate of survival of treated patients was remarkably high: at 2 years, 62% were alive, as compared with 18% of contemporary controls with a similar disease stage, surgical-resection grade, and baseline treatment…”
“A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme…
“Antiviral therapy against cytomegalovirus (CMV) — typically only thought a threat in immunosuppressed patients — was linked to dramatically improved survival in patients with glioblastoma, based on one center’s experience…The results were even better in the subgroup treated longer, up to 70% and 90% 2-year survival…”
Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.
“CONCLUSION: These results suggest that intrathecal treatment with PVS-RIPO may be useful for treatment of neoplastic meningitis in patients with glioblastoma multiforme and provides a rationale for clinical trials in this area..”
YouTube video talking about the above therapy on a live GBM cancer patient-http://www.youtube.com/watch?v=UHmQnGsWiIM